Vaxxas is disrupting and revolutionizing the way vaccines are delivered, through their innovative Nanopatch™.

The R&D Tax Incentive helped attract further investment in our company and open up more chances for collaboration with large pharma companies, universities and philanthropic organisations around the world.
— Angus Foster, Chief Development and Operations Manager, Vaxxas

Company Profile

Company: Vaxxas Pty Ltd

Sector: Biotechnology

Location: Brisbane

Profile: Vaxxas is a medical technology start-up located in Brisbane, revolutionizing the way vaccines are delivered. Vaccinations have historically been given using syringes and needles; however through Research & Development, Vaxxas has been able to develop their Nanopatch – a less invasive vaccine delivery technology that creates a more potent immune response.